Dr. Ritika Vankina, MD

Dr. Vankina practices at Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut.

Dr. Vankina's NPI, 1811314263, was assigned on March 24, 2014. Dr. Vankina holds Connecticut license 066330.

Dr. Vankina's primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD, at 263 Farmington Ave, Farmington, CT 06030.

Dr. Vankina's primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut. Dr. Vankina is also affiliated with UConn John Dempsey Hospital. The medical group on file is UConn Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vankina practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Vankina's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Vankina is licensed in Connecticut.

CMS data shows 226 Medicare services from Dr. Vankina across 8 procedure codes in 2024, for 105 Medicare patients. Medicare paid $17,146 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 105 Medicare patients who saw Dr. Vankina in 2024. The largest group is 75 to 84, with 34 patients. 71% of them have high blood pressure, and 60% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vankina's median patient age at 71, with 53% women.

In 2024, Dr. Vankina wrote 428 Medicare Part D claims for 96 patients. 35% of them were for generic drugs. CMS names the drug for 341 of them, across 6 drugs with 11 or more claims each, at $534,299 in total drug cost. In 2023, CMS named 186 claims across 5 drugs.

Dr. Vankina accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vankina as offering telehealth.

CMS Open Payments shows 56 general payments to Dr. Vankina from 14 drug and device companies from 2017 to 2020. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $341.